诺贝尔物理/化学/医学奖获奖更佳年龄分布

2016-10-08 诸平 科学网

1901年以来到2016年,诺贝尔物理学奖、化学奖以及生理或医学奖共颁奖325次,共计有590人次获奖,那么这些获奖者在获奖时的年龄分布有何规律?究竟何时年龄段获奖人数最多?即不同学科的诺贝尔奖获得者,获奖最佳年龄同样值得我们关注。1 平均年龄1901-2016年诺贝尔奖当中的物理/化学/医学奖的颁奖次数与获奖者以及平均年龄统计结果见表1。表1 1901-2016年诺贝尔物理/化学/医学

1901年以来到2016年,诺贝尔物理学奖、化学奖以及生理或医学奖共颁奖325次,共计有590人次获奖,那么这些获奖者在获奖时的年龄分布有何规律?究竟何时年龄段获奖人数最多?即不同学科的诺贝尔奖获得者,获奖最佳年龄同样值得我们关注。

1 平均年龄

1901-2016年诺贝尔奖当中的物理/化学/医学奖的颁奖次数与获奖者以及平均年龄统计结果见表1

1 1901-2016年诺贝尔物理/化学/医学奖统计结果

奖项分类

物理学奖

化学奖

医学或生理学奖

合计

颁奖次数

110

108

107

325

获奖者/人次

204

175

211

590

平均年龄/

55

58

58

57

总年龄/

11305

10178

12203

33686


2 获奖年龄分布

由图1可知,物理学奖得主获奖时年龄在45-49岁之间的人数最多;而化学奖得主获奖时年龄在50-54岁之间的人数最多,但是,生理学或医学奖得主获奖时的年龄要更大一些,高峰期是在60-64岁之间,这些也可以视为获得诺贝尔奖的最佳年龄段。除此之外,物理学奖获奖时的次佳年龄段是在40-64岁之间,获奖人数仅次于最佳年龄段,而且基本相当(除最佳年龄段45-49岁之外);而化学奖获奖时的次佳年龄段在55-64岁之间,也是获奖人数较多的年龄段;生理学或医学奖获奖时的次佳年龄段是在45-59岁之间,获奖人数仅次于最佳年龄段,而且获奖人数较多。

1 1901-2016年诺贝尔物理/化学/医学奖得主年龄统计结果

3 阶段性平均年龄变化

由图2可知,1901-2016年诺贝尔物理/化学/医学奖得主10年分段平均年龄统计结果显示,3个奖项的共同特征是10年平均年龄在逐渐增大。


2 1901-2016年诺贝尔物理/化学/医学奖得主阶段性平均年龄统计结果

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1763966, encodeId=bfd81e639666d, content=<a href='/topic/show?id=ecf88800939' target=_blank style='color:#2F92EE;'>#获奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88009, encryptionId=ecf88800939, topicName=获奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Dec 07 19:41:00 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543474, encodeId=b36615434e4a2, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Mon Oct 10 01:41:00 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142317, encodeId=651114231e01, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:35:40 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142316, encodeId=26631423168f, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:35:28 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142014, encodeId=8f2314201407, content=好厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/04/987ab7c2833e61f380d4bd473e6d53ad.jpg, createdBy=9f6e1919285, createdName=好好先, createdTime=Sat Oct 08 11:26:25 CST 2016, time=2016-10-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1763966, encodeId=bfd81e639666d, content=<a href='/topic/show?id=ecf88800939' target=_blank style='color:#2F92EE;'>#获奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88009, encryptionId=ecf88800939, topicName=获奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Dec 07 19:41:00 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543474, encodeId=b36615434e4a2, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Mon Oct 10 01:41:00 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142317, encodeId=651114231e01, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:35:40 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142316, encodeId=26631423168f, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:35:28 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142014, encodeId=8f2314201407, content=好厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/04/987ab7c2833e61f380d4bd473e6d53ad.jpg, createdBy=9f6e1919285, createdName=好好先, createdTime=Sat Oct 08 11:26:25 CST 2016, time=2016-10-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1763966, encodeId=bfd81e639666d, content=<a href='/topic/show?id=ecf88800939' target=_blank style='color:#2F92EE;'>#获奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88009, encryptionId=ecf88800939, topicName=获奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Dec 07 19:41:00 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543474, encodeId=b36615434e4a2, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Mon Oct 10 01:41:00 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142317, encodeId=651114231e01, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:35:40 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142316, encodeId=26631423168f, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:35:28 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142014, encodeId=8f2314201407, content=好厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/04/987ab7c2833e61f380d4bd473e6d53ad.jpg, createdBy=9f6e1919285, createdName=好好先, createdTime=Sat Oct 08 11:26:25 CST 2016, time=2016-10-08, status=1, ipAttribution=)]
    2016-10-09 知难而进

    谢谢分享!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1763966, encodeId=bfd81e639666d, content=<a href='/topic/show?id=ecf88800939' target=_blank style='color:#2F92EE;'>#获奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88009, encryptionId=ecf88800939, topicName=获奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Dec 07 19:41:00 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543474, encodeId=b36615434e4a2, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Mon Oct 10 01:41:00 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142317, encodeId=651114231e01, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:35:40 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142316, encodeId=26631423168f, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:35:28 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142014, encodeId=8f2314201407, content=好厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/04/987ab7c2833e61f380d4bd473e6d53ad.jpg, createdBy=9f6e1919285, createdName=好好先, createdTime=Sat Oct 08 11:26:25 CST 2016, time=2016-10-08, status=1, ipAttribution=)]
    2016-10-09 知难而进

    继续关注!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1763966, encodeId=bfd81e639666d, content=<a href='/topic/show?id=ecf88800939' target=_blank style='color:#2F92EE;'>#获奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88009, encryptionId=ecf88800939, topicName=获奖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Dec 07 19:41:00 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543474, encodeId=b36615434e4a2, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Mon Oct 10 01:41:00 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142317, encodeId=651114231e01, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:35:40 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142316, encodeId=26631423168f, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Sun Oct 09 00:35:28 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=142014, encodeId=8f2314201407, content=好厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/04/987ab7c2833e61f380d4bd473e6d53ad.jpg, createdBy=9f6e1919285, createdName=好好先, createdTime=Sat Oct 08 11:26:25 CST 2016, time=2016-10-08, status=1, ipAttribution=)]
    2016-10-08 好好先

    好厉害

    0

相关资讯

抗老+抑癌,尚未产业应用的诺奖新秀会被催生出泡沫吗?

导语:相比较去年轰轰烈烈带动了一排股票涨停的青蒿素,今年的诺贝尔或许会让市场失望了。据了解,尽管细胞自噬可以用于对抗衰老、癌症,阿尔茨海默等多种疾病,但在目前全球范围尚未触及真正的临床产业应用。诺奖的热度会让这个现象级而不是产业级的研究催生出泡沫吗,但愿不要这样才好。(1945年2月9日-),日本分子细胞生物学家。现任综合研究大学院大学名誉教授、基础生物学研究所名誉教授、东京工业大学前沿研究机构特

同样是举国体制,日本靠这样的诺奖战略本世纪已得奖15次

昨天,2016年诺贝尔生理学或医学奖揭开面纱,日本分子细胞生物学家、京都工业大学大隅良典因其在自噬性溶酶体方面做出的贡献而摘得桂冠,并获得奖金800万瑞典克朗,约合625万人民币。至此,包括大隅良典在内,已经有25名日本或日本裔学者获得诺贝尔奖,包括11项物理奖、7项化学奖和4项生理学或医学奖。在过去15年间,平均每年一人获得诺奖。可以说,进入新世纪后,日本科学家获得诺奖已呈现“井喷”之势,形

2016年诺贝尔奖得主Yoshinori Ohsumi的自噬研究情怀

北京时间10月3日下午17:30,2016年诺贝尔生理学或医学奖揭晓,来自东京工业大学的研究者Yoshinori Ohsumi(大隅良典)因发现自噬(autophagy)的机制而获得此奖。 Yoshinori Ohsumi的研究发现开启了科学家揭示细胞循环自身内容物的新纪元,他的研究发现为理解许多机体生理学过程中自体吞噬奠定了坚实的基础,比如机体如何适应饥

10条黄金法则教你如何获“诺贝尔奖”:CRISPR未获奖

导语:本以为生理学或医学奖揭晓后,小编就可以安心过(养)节(膘)了。但自去年起,颠覆性的基因编辑技术CRISPR就开始出现在了化学领域的预测名单中。一直跟踪CRISPR新闻的小编不得不再次打开诺奖官网,等待惊(加)喜(班)的到来10月5日,2016诺贝尔化学奖揭晓。法国斯特拉斯堡大学的Jean-Pierre Sauvage、美国西北大学的Sir J. Fraser Stoddart和荷兰格罗宁

诺贝尔奖是怎么火起来的?

相信关注科学的你被诺贝尔生理学或医学奖的消息刷了屏。如果说诺贝尔奖是世界上最富盛名的科学奖项,恐怕没有多少人会反对。从图灵奖被称为“计算机领域的诺贝尔奖”就可以看出,诺贝尔奖已超越了本身,成为了一种文化符号。可是,诺贝尔奖是怎么火起来的呢?▲阿尔弗雷德·诺贝尔博士希望能用自己的财富来表彰为人类做出卓越贡献的个体(图片来源:诺贝尔奖官网)这个故事还要从1888年说起。当时,一家法国报纸刊登了阿尔弗雷